“…In a previous study involving this dataset, the authors demonstrated that growth rate was also not affected by biopsy proof of malignancy and that progression to metastasis occurred in only 1.1% of patients. 2 This current study has its limitations, including radiological follow-up using different imaging modalities (computed tomography, magnetic resonance imaging, ultrasonography), which can provide subtle measurement differences when compared, a lack of central radiological review, the use of maximum diameter instead of tumour volume and the absence of precise tumour location (exophytic vs. endophytic or sinus based). Yet, despite these limitations, an important message can be gleaned.…”